These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32419542)

  • 1. Phenotypic analysis of tumor-infiltrating lymphocytes from non-small cell lung cancer and their potential application for adoptive cell therapy.
    Ma Y; Ou J; Lin T; Chen L; Wang J; Qiao D; Lai S; Duan C; Cheng Y; Chang R; Zhang C; Wang M
    Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):319-329. PubMed ID: 32419542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients.
    Ben-Avi R; Farhi R; Ben-Nun A; Gorodner M; Greenberg E; Markel G; Schachter J; Itzhaki O; Besser MJ
    Cancer Immunol Immunother; 2018 Aug; 67(8):1221-1230. PubMed ID: 29845338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Characteristics of Naive-like T Cells in Tumor-infiltrating Lymphocytes From Human Lung Cancer.
    Sheng SY; Gu Y; Lu CG; Tang YY; Zou JY; Zhang YQ; Wang RF; Hong H
    J Immunother; 2017 Jan; 40(1):1-10. PubMed ID: 27828929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-Presenting Intratumoral B Cells Affect CD4
    Bruno TC; Ebner PJ; Moore BL; Squalls OG; Waugh KA; Eruslanov EB; Singhal S; Mitchell JD; Franklin WA; Merrick DT; McCarter MD; Palmer BE; Kern JA; Slansky JE
    Cancer Immunol Res; 2017 Oct; 5(10):898-907. PubMed ID: 28848053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4
    Jiménez-Reinoso A; Molero-Abraham M; Cirauqui C; Blanco B; Garrido-Martin EM; Nehme-Álvarez D; Domínguez-Alonso C; Ramírez-Fernández Á; Díez-Alonso L; Nuñez-Buiza Á; González-Murillo Á; Tobes R; Pareja E; Ramírez-Orellana M; Rodriguez-Peralto JL; Ferrer I; Zugazagoitia J; Paz-Ares L; Álvarez-Vallina L
    Oncoimmunology; 2024; 13(1):2392897. PubMed ID: 39206095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer.
    Braun MW; Abdelhakim H; Li M; Hyter S; Pessetto Z; Koestler DC; Pathak HB; Dunavin N; Godwin AK
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33037114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes.
    Shah P; Forget MA; Frank ML; Jiang P; Sakellariou-Thompson D; Federico L; Khairullah R; Neutzler CA; Wistuba I; Chow CB; Long Y; Fujimoto J; Lin SY; Maitra A; Negrao MV; Mitchell KG; Weissferdt A; Vaporciyan AA; Cascone T; Roth JA; Zhang J; Sepesi B; Gibbons DL; Heymach JV; Haymaker CL; McGrail DJ; Reuben A; Bernatchez C
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35110355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer.
    Rakaee M; Kilvaer TK; Dalen SM; Richardsen E; Paulsen EE; Hald SM; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Busund LT
    Hum Pathol; 2018 Sep; 79():188-198. PubMed ID: 29885403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of oligoclonal T lymphocytes in lymph nodes draining from advanced non-small-cell lung cancer.
    Meta M; Ponte M; Guastella M; Semino C; Pietra G; Ratto GB; Melioli G
    Cancer Immunol Immunother; 1995 Apr; 40(4):235-40. PubMed ID: 7750121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and in vitro expansion of lymphocytes infiltrating non-small cell lung carcinoma: functional and molecular characterisation for their use in adoptive immunotherapy.
    Melioli G; Ratto G; Guastella M; Meta M; Biassoni R; Semino C; Casartelli G; Pasquetti W; Catrullo A; Moretta L
    Eur J Cancer; 1994; 30A(1):97-102. PubMed ID: 8142173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs).
    Nguyen LT; Yen PH; Nie J; Liadis N; Ghazarian D; Al-Habeeb A; Easson A; Leong W; Lipa J; McCready D; Reedijk M; Hogg D; Joshua AM; Quirt I; Messner H; Shaw P; Crump M; Sharon E; Ohashi PS
    PLoS One; 2010 Nov; 5(11):e13940. PubMed ID: 21085676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products.
    Castenmiller SM; Kanagasabesan N; Guislain A; Nicolet BP; van Loenen MM; Monkhorst K; Veenhof AAFA; Smit EF; Hartemink KJ; Haanen JBAG; de Groot R; Wolkers MC
    Oncoimmunology; 2024; 13(1):2392898. PubMed ID: 39188755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of stage IIIB non-small-cell lung cancer with surgery followed by infusion of tumor infiltrating lymphocytes and recombinant interleukin-2: a pilot study.
    Melioli G; Ratto GB; Ponte M; Guastella M; Semino C; Fantino G; Tassara E; Pasquetti W; Mereu C; Merlo F; Reggiardo G; Morasso G; Santi L; Moretta L
    J Immunother Emphasis Tumor Immunol; 1996 May; 19(3):224-30. PubMed ID: 8811497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the potential of adoptive cell therapy.
    Choi S; Hossain M; Lee H; Baek J; Park HS; Lim CL; Han D; Park T; Kim JH; Gong G; Kweon MN; Lee HJ
    Cancer Immunol Immunother; 2024 Apr; 73(6):101. PubMed ID: 38630265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
    Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of tumor-infiltrating lymphocytes in non-small cell lung cancer: Clinical potential and efficacy in EGFR mutation subsets.
    Lee H; Lee M; Lim CL; Park HS; Song IH; Jeong BK; Kim DK; Kim YH; Choi S; Lee GD; Lee SB; Jung S; Gong G; Kim SB; Yoo C; Kim JY; Lee HJ
    Clin Immunol; 2024 Aug; 265():110289. PubMed ID: 38908769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Heterogeneity of CD4
    Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
    Front Immunol; 2018; 9():2654. PubMed ID: 30505306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Microenvironment Differences Between Squamous and Non-squamous Non-small-cell Lung Cancer and Their Influence on the Prognosis.
    Meng X; Gao Y; Yang L; Jing H; Teng F; Huang Z; Xing L
    Clin Lung Cancer; 2019 Jan; 20(1):48-58. PubMed ID: 30341017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy.
    Einstein DJ; Halbert B; Denize T; Matar S; West DJ; Gupta M; Andrianopoulos E; Seery V; Herman C; Onimus K; Wells A; Bunch B; Signoretti S; Natarajan A; Veerapathran A; McDermott DF
    J Immunother; 2024 Nov-Dec 01; 47(9):361-368. PubMed ID: 38995718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
    Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
    J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.